NCT00002305已完成不适用
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Pfizer
- 试验地点
- 89
研究概览
简要总结
To compare the safety and effectiveness of fluconazole and amphotericin B, alone or in combination with flucytosine, as treatment for acute cryptococcal meningitis.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (89)
Loading locations...
相似试验
已完成
不适用
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisMeningitis, CryptococcalHIV InfectionsNCT00002075Pfizer
已完成
不适用
A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisMeningitis, CryptococcalHIV InfectionsNCT00002068Pfizer
已完成
不适用
Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisMeningitis, CryptococcalHIV InfectionsNCT00000708National Institute of Allergy and Infectious Diseases (NIAID)120
已完成
不适用
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency SyndromeMeningitis, CryptococcalHIV InfectionsNCT00002074Pfizer
已完成
3 期
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal InfectionsMycosesHIV InfectionsNCT00002277Pfizer